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Abstract 
Background: Spontaneous rupture is one of the most fatal complications of HCC. The incidence of HCC still remains 
a significant health problem in Eastern Asia. Many studies have shown that the in‑hospital or 30‑day mortality rates 
are as high as 25–100 %. It is often difficult to stratify these patients based on clinical manifestations and biochemi‑
cal data, for deciding on an appropriate treatment strategy, especially when the patient’s hemodynamic status is 
unstable. This study aimed to explore the clinical outcomes of treatment of spontaneously ruptured hepatocellular 
carcinoma with hemorrhagic shock.
Methods: One hundred and sixty two patients with hemorrhagic shock secondary to spontaneous rupture of 
hepatocellular carcinoma were included in this retrospective study. The therapeutic methods included conservative 
treatment, transcatheter arterial embolization (TAE) and hepatectomy. The outcomes in terms of 30 day and 1 year 
survival were analyzed.
Results: Thirty five (21.6 %) received only conservative management, TAE was performed in 48 (29.6 %) and partial 
hepatectomy (emergency and staged) in 106 (65.4 %) patients. The 30‑day survival rate was lower in patients receiv‑
ing conservative treatment (8.6 %) than in those receiving either hepatectomy or TAE (88.2 %; P < 0.001). Conservative 
treatment was associated with poorer long‑term survival (0 % at 1 year) when compared to those receiving either 
hepatectomy or TAE (54.3 % at 1 year; P < 0.001). The survival rates at 30 days and 1 year were 92.5 % and 59.4 % for 
the patients who underwent hepatectomy, which were significantly higher (66.7 and 28.6 % respectively) than those 
receiving TAE alone (P = 0.003 and P = 0.009, respectively). Multivariate Cox‑regression analysis showed that hepatec‑
tomy and TAE were significant protective factors for survival as compared with conservative treatment (all P < 0.01).
Conclusions: Partial hepatectomy, tended to provide better survival than transcatheter arterial embolization alone or 
conservative treatment in the management of patients with hemorrhagic shock secondary to spontaneous rupture of 
hepatocellular carcinoma.
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Background
Spontaneous rupture is one of the most fatal complica-
tions of hepatocellular carcinoma (HCC) and possesses a 
geographically variable incidence. In Western countries, 
the incidence of ruptured HCC is less than 3  % (Yama-
gata et al. 1995; Vergara et al. 2000; Clarkston et al. 1998). 
However, in Asia, spontaneous rupture occurs in 2.3–
26 % of all HCC case (Chen et al. 1995; Miyamoto et al. 
1991; Dewar et al. 1991; Yuan et al. 2004; Liu et al. 2001). 
The incidence of ruptured HCC has reduced in the recent 
past, owing to the early diagnosis, but this condition still 
remains a significant health problem in Eastern Asia. 
Many studies have shown that the in-hospital or 30-day 
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mortality rates are as high as 25–100 % (Liu et al. 2001; 
Chen et al. 2005; Darnis et al. 2014; Kirikoshi et al. 2009; 
Lai and Lau 2006; Lee et  al. 2014; Lin et  al. 2014; Tan 
et al. 2006). In most cases, spontaneous rupture of HCC 
occurs suddenly, and these patients usually present to 
the emergency department with abdominal pain and/or 
hypotension (Chen et al. 2005; Darnis et al. 2014; Lai and 
Lau 2006; Lin et  al. 2014; Hsueh et  al. 2012; Yang et  al. 
2013). It is often difficult to stratify these patients based 
on clinical manifestations and biochemical data, for 
deciding on an appropriate treatment strategy, especially 
when the patient’s hemodynamic status is unstable. Stud-
ies have shown that several therapies such as hepatec-
tomy, surgical ligation of the hepatic artery, perihepatic 
packing, and transcatheter arterial embolization (TAE) 
improve clinical outcomes (Vergara et  al. 2000; Kiriko-
shi et al. 2009; Lai and Lau 2006; Choi et al. 2001). The 
tumor characteristics and liver function guide the choice 
of treatment and affect prognosis (Vergara et  al. 2000; 
Chen et  al. 2005; Lai and Lau 2006; Choi et  al. 2001). 
Some experts prefer TAE or conservative management 
(Tan et al. 2006; Yang et al. 2013; Kim et al. 2012; Kung 
et  al. 2008; Li et  al. 2009; Yeh et  al. 2002), while others 
consider emergency hepatectomy or staged hepatectomy 
after TAE for ruptured HCC to be a better therapeutic 
option (Lee et al. 2014; Lin et al. 2014; Hsueh et al. 2012; 
Yang et al. 2013; Zhang et al. 2015; Li et al. 2007; Jin et al. 
2013). To the best of our knowledge, till date, no prospec-
tive randomized controlled trials to directly compare 
these method of hemostasis have been published. Addi-
tionally, there is no consensus on the most appropriate 
treatment modality.
There are a few multicenter studies on spontaneously 
ruptured HCC, but none investigated the treatment out-
comes for this condition with associated hemorrhagic 
shock in a large study population in a multicenter setting. 
In this study, we analyzed the data of spontaneously rup-
tured HCC presenting with hemorrhagic shock during a 
10-year period at three medical centers. This study aimed 
to explore the immediate and long term clinical out-
comes of emergency hepatectomy, staged hepatectomy, 
TAE alone and conservative treatment in spontaneously 
ruptured hepatocellular carcinoma with hemorrhagic 
shock.
Methods
A total of 162 patients with a diagnosis of spontane-
ous rupture of HCC with hemorrhagic shock admitted 
to Nanfang Hospital (42 patients; a university hospital), 
Nanshan Hospital (89 patients; a university hospital) 
and Jiangmen People’s Hospital (31 patients; a central 
hospital), China between January 2004 and January 
2014, were enrolled. After approval from the Nanfang 
Hospital Institutional Review Board, the Nanshan Hos-
pital Ethical Committee and the Jiangmen People’s Hos-
pital Ethical Committee, the data was extracted from 
database records and hospital charts. One hundred and 
six patients were diagnosed with ruptured HCC based 
on intraoperative exploration findings. In the rest of the 
patients (56), diagnosis was made on the basis of dynamic 
contrast-enhanced abdominal CT with typical findings 
of a ruptured HCC, including active extravasation of 
contrast material, HCC with a surrounding perihepatic 
hematoma showing high attenuation, protrusion of the 
contour, focal discontinuity of the hepatic surface, and 
an enucleation sign or identification of hemorrhagic fluid 
by abdominal paracentesis (with more than 100,000,000 
erythrocytes/mL of ascetic fluid). Circulatory shock 
was defined as a systolic blood pressure <90  mmHg 
(1 mmHg = 0.133 kPa) and a pulse rate >100 beats/min.
The clinical data was retrospectively reviewed from the 
medical records. The patients were diagnosed based on 
medical history, physical examination, contrast-enhanced 
abdominal CT scan, and abdominal sonography with 
paracentesis. The demographics, past medical history, 
hemodynamic status, associated laboratory data, diag-
nostic methods, Modified Union for International Can-
cer Control (UICC) stage (Liver Cancer Study Group of 
Japan 1989), tumor characteristics on imaging, and treat-
ment modalities were recorded.
Evaluation of patients
The patients were monitored closely either in the ward or 
the intensive care unit. After initial fluid resuscitation, all 
patients were classified either as hemodynamically stable 
or unstable. Liver function was monitored closely before 
definite treatment decision making. Tumor characteris-
tics, including greatest dimension, location of rupture, 
and number of intrahepatic nodules, were evaluated by 
ultrasonography or abdominal CT scan.
Treatment modality of ruptured HCCs
The patients and their family members were explained 
about the four management options of emergency hepa-
tectomy, staged hepatectomy, TAE and best supportive 
care (conservative management) with relative benefits 
and risks of each. Criteria for emergency surgical treat-
ment included: (1) patients with stable hemodynamic 
after initial fluid resuscitation; (2) patients were expect-
edly able to tolerate surgery; (3) patients and their 
relatives agreed to undergo surgery. Criteria for TAE 
treatment were: (1) patients were expectedly able to tol-
erate TAE treatment; (2) patients and their relatives 
agreed to undergo TAE treatment. Criteria for staged 
surgery included: (1) patients with stable hemodynamic 
after TAE therapy; (2) patients can tolerate surgery; (3) 
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the tumor was expectedly to be removed, (4) patients 
and their relatives agreed to undergo surgery. Criteria 
for conservative treatment were: (1) patients and their 
relatives did not agree to undergo either surgery or TAE 
treatment; (2) patients were expectedly unable to tolerate 
either surgery or TAE treatment. Written informed con-
sent was obtained from all patients and a family member 
before any of the treatment procedures. One of the four 
therapeutic options was undertaken after initial resusci-
tation and stabilization. Emergency hepatectomy refers 
to the performance of surgery with ruptured HCC as 
the primary treatment, and staged hepatectomy refers to 
initial hemostasis by TAE (embolization of the feeding 
artery was performed with gelfoam containing approxi-
mately 1 mm3 sized absorbable gelatin sponge particles), 
followed by partial hepatectomy several days later (Hsueh 
et al. 2012).
The extent of hepatectomy performed depends upon 
the tumor and residual liver parameters in addition to 
operating surgeon’s clinical judgment. It was either a 
lobectomy, a monosegmentectomy, a bisegmentectomy 
or a wedge hepatectomy with ligation of the feeding 
artery. Successful hemostasis was defined as hemody-
namic stabilization, stable hemoglobin level, and no 
requirement for further transfusion.
Statistical analysis
Categorical variables were indicated using counts and 
percentages (%). The measured data were expressed as 
mean  ±  SD. Differences between continuous variables 
were analyzed using one-way ANOVA and Fisher’s LSD 
test as post hoc. Categorical variables were compared 
using χ2 test or Fisher’s exact test. Kaplan–Meier survival 
curves were used for survival analysis, and the difference 
among groups were compared using log-rank test. Uni-
variate and multivariate Cox-regression were utilized to 
investigate independent variables which were associated 
with overall survival. In this study, the final follow-up 
date was February28, 2015. All patients were followed up 
for ≥1 year. Statistical analysis was performed using IBM 
SPSS for Windows version 19 (SPSS, Chicago, IL, USA). 
Two-tailed P  <  0.05 was considered statistically signifi-
cant in all tests.
Results
Clinical characteristics of patients
The demographic and clinical data of 162 patients in 
four groups is summarized in Table  1. There were 136 
(84.0  %) men and 26 (16.0  %) women, with a mean age 
of 58.0 ± 6.4 years. One hundred and thirty-two (81.5 %) 
patients had hepatitis-B virus (HBV) infection and 142 
(87.7 %) had liver cirrhosis. Seventy-four (45.7 %) of the 
162 patients were classified as Child-Pugh class A, 44 
(27.2 %) as class B, and 44 (27.2 %) as class C. The mean 
size of lesions was 8.9  ±  1.9  cm. Twenty-five patients 
(15.4 %) were classified as stage II HCC as proposed by 
the Liver Cancer Study Group of Japan (Ueno et al. 2002), 
56 as stage III (34.6 %), 72 as stage IVA (44.4 %), and nine 
as stage IVB (5.6 %). The morphology of lesions in all 162 
patients included four types: 32 (19.8 %) nodular type, 38 
(23.5  %) infiltrative type, 83 (51.2  %) pedunculated type 
and 9 (5.6 %) cirrhotomimetic type. Among all the char-
acteristics, age, liver cirrhosis, Child Pugh stage, hemo-
globin, platelet, international normalized ratio (INR), 
albumin, total bilirubin, creatinine, modified UICC stage 
and morphology of lesions were significantly different 
among four groups (all P < 0.05).
Treatment and outcomes
All patients received initial intravenous fluid resuscita-
tion, supportive care and blood products as required 
in the intensive care unit immediately after admission. 
Treatment decisions were taken on individual case basis 
taking into consideration the patients’ performance sta-
tus, organ functions, comorbidities and the wishes of 
the patient and families. Of the 162 patients, 35 (21.6 %) 
patients received only medical treatment and fluid ther-
apy (conservative treatment group, n  =  35) in view of 
their poor liver function and/or multiple lesions or the 
wishes of the families. TAE hemostasis was performed in 
48 (29.6 %) patients (TAE alone group, n = 21 and staged 
surgery group, n = 27) in view of their poor liver func-
tion, absence of contraindications to the procedure or the 
wishes of the families. All the 48 patients underwent TAE 
were of successful embolization. Partial hepatectomy was 
the definitive treatment in 106 (65.4  %) patients. With 
respect to the surgical methods used, wedge resection of 
the tumor was performed in 16 patients, monosegmen-
tectomy in 19, bisegmentectomy in 22, and lobectomy in 
49. Seventy-nine patients had surgery immediately after 
primary resuscitation (emergency surgery group, n = 79), 
and the remaining 27 underwent staged partial hepatec-
tomy 1–10 d after TAE (staged surgery group, n = 27).
Causes of death within 30 days
Forty seven of the 162 patients died within 30 days in the 
hospital. Most of the patients in the conservative treat-
ment group died within 30 days of hospitalization during 
the first admission, and the chief cause of death in this 
group was re-bleeding of HCC (21 cases; 65.6 %). In the 
TAE-only group, 14 patients (66.7  %) were discharged 
from hospital and 7 died within 30  days. The main 
cause of death in the TAE-only group was liver failure (4 
patients, 57.1 %), and only two (28.6 %) died of re-rupture 
or re-bleeding of HCC. In the hepatectomy group (emer-
gency and staged), fewer patients died within 30  days 
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(Table 2). The distribution of cause of death did not sig-
nificantly differ in different groups (P = 0.211).
Overall survival
The survival rates of all 162 patients at 30 days and 1 year 
were 71.0 % (115/162) and 42.6 % (69/162). The survival 
rates at 30  days and 1  year in the patients who under-
went conservative treatment were 8.6  % (3/35) and 0  % 
(0/35), respectively. These rates were significantly lower 
than those receiving either hepatectomy or TAE (88.2 %; 
112/127 and 54.3  %; 69/127; χ2  =  84.45, P  <  0.001 and 
χ2  =  33.12, P  <  0.001). The overall cumulative survival 
rates among four treatment groups reached significant 
difference (Log-rank test, P  <  0.001, Fig.  1). The cumu-
lative survival rates of the patients undergoing either 
hepatectomy or TAE were higher than those receiving 
conservative treatment (Log-rank test, P < 0.001, Fig. 2). 
The patients who underwent hepatectomy (emergency 
or staged) showed better cumulative survival than those 
receiving TAE alone (Log-rank test, P < 0.001; Fig. 3). The 
survival rate at 30 days for the patients who underwent 
hepatectomy was 92.5 % (98/106), which was higher than 
those receiving TAE alone (66.7  %; 14/21; P  =  0.003). 
The survival rate at 1 year was also superior in patients 
Table 1 The clinical data of 162 patients with hemorrhagic shock and spontaneous rupture of HCC














Age (years) 53.6 ± 5.9 61.5 ± 3.3 58.3 ± 4.6 58.8 ± 6.8 58.0 ± 6.4 <0.001***
Gender (male) 29 (82.9 %) 15 (71.4 %) 24 (88.9 %) 68 (86.1 %) 136 (84.0 %) 0.404
Etiology 0.226
 HBV 26 (74.3 %) 18 (85.7 %) 23 (85.2 %) 65 (82.3 %) 132 (81.5 %)
 HCV 3 (8.6 %) 3 (14.3 %) 3 (11.1 %) 6 (7.6 %) 15 (9.3 %)
 Others 6 (17.1 %) 0 (.0 %) 1 (3.7 %) 8 (10.1 %) 15 (9.3 %)
Liver cirrhosis (yes) 35 (100.0 %) 21 (100.0 %) 20 (74.1 %) 66 (83.5 %) 142 (87.7 %) <0.001***
Child‑Pugh stage <0.001***
 A 3 (8.6 %) 3 (14.3 %) 15 (55.6 %) 53 (67.1 %) 74 (45.7 %)
 B 9 (25.7 %) 9 (42.9 %) 9 (33.3 %) 17 (21.5 %) 44 (27.2 %)
 C 23 (65.7 %) 9 (42.9 %) 3 (11.1 %) 9 (11.4 %) 44 (27.2 %)
Hemoglobin (g/L) 83.9 ± 6.2 95.7 ± 11.2 91.5 ± 4.6 91.3 ± 9.7 90.3 ± 9.3 <0.001***
Platelet (×109/L) 106.7 ± 14.7 132.1 ± 47.0 117.6 ± 19.9 108.7 ± 16.2 112.8 ± 24.1 <0.001***
INR 2.4 ± 1.3 1.4 ± .2 1.3 ± .2 1.5 ± .3 1.6 ± .7 <0.001***
Albumin (g/L) 29.2 ± 4.8 34.1 ± 3.7 32.6 ± 3.6 33.5 ± 3.4 32.5 ± 4.2 <0.001***
Total bilirubin (mmol/L) 61.9 ± 35.2 20.5 ± 6.3 24.4 ± 8.9 24.9 ± 11.6 32.3 ± 24.3 <0.001***
ALT (IU/L) 182.6 ± 152.6 143.2 ± 59.6 191.8 ± 79.3 148.1 ± 77.2 162.2 ± 98.2 0.094
Creatinine (mg/dL) 1.1 ± .1 1.3 ± .1 1.3 ± .2 1.3 ± .2 1.3 ± .2 <0.001***
AFP (µg/L) 7532.9 ± 5515.6 9136.7 ± 2421.3 9836.3 ± 6619.4 8518.0 ± 6895.8 8605.1 ± 6149.1 0.513
Size of lesions (cm) 8.8 ± 1.6 9.0 ± 2.0 9.0 ± 1.4 8.8 ± 2.3 8.9 ± 1.9 0.959
Multiple tumors (yes) 20 (57.1 %) 9 (42.9 %) 12 (44.4 %) 34 (43.0 %) 75 (46.3 %) 0.546
Portal vein (yes) 12 (34.3 %) 9 (42.9 %) 9 (33.3 %) 29 (36.7 %) 59 (36.4 %) 0.906
Modified UICC stage 0.002**
 2 6 (17.1 %) 3 (14.3 %) 1 (3.7 %) 15 (19.0 %) 25 (15.4 %)
 3 6 (17.1 %) 9 (42.9 %) 17 (63.0 %) 24 (30.4 %) 56 (34.6 %)
 4A 17 (48.6 %) 9 (42.9 %) 9 (33.3 %) 37 (46.8 %) 72 (44.4 %)
 4B 6 (17.1 %) 0 (.0 %) 0 (.0 %) 3 (3.8 %) 9 (5.6 %)
Morphology of lesions <0.001***
 Nodular 1 (2.9 %) 3 (14.3 %) 13 (48.1 %) 15 (19.0 %) 32 (19.8 %)
 Infiltrative 10 (28.6 %) 5 (23.8 %) 0 (.0 %) 23 (29.1 %) 38 (23.5 %)
 Pedunculated 18 (51.4 %) 11 (52.4 %) 14 (51.9 %) 40 (50.6 %) 83 (51.2 %)
 Cirrhotomimetic 6 (17.1 %) 2 (9.5 %) 0 (.0 %) 1 (1.3 %) 9 (5.6 %)
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who underwent hepatectomy (59.4 %; 63/106) compared 
to those receiving TAE alone (28.6  %; 6/21) (χ2 =  6.73, 
P = 0.009). There was no significant difference between 
the cumulative survival rates of emergency hepatec-
tomy and the rates of staged hepatectomy (χ2  =  2.63, 
P = 0.105).  
Independent variables associated with overall survival
To adjust for potential confounders including all the 
demographic and clinical characteristics, Cox-regression 
was utilized to analyze prognostic factors for overall sur-
vival. The results of univariate Cox-regression (estimated 
hazard ratio [HR]) and multivariate model (adjusted 
HR) adjusted for all other factors were shown in Table 3. 
Variables significant in both univariate and multivariate 
regression would be regarded as a prognostic factor for 
overall survival of patients. Consistent with the result 
of cumulative survival analysis, stated surgery [hazard 
ratio (HR) 0.02; 95 % confidence interval (CI) 0.00–0.09; 
P  <  0.001], emergency surgery (HR 0.13; 95  % CI  0.03–
0.50; P = 0.003) and TAE therapy (HR 0.05; 95 % CI 0.02–
0.170; P  <  0.001) were significant protective factors for 
survival as compared with conservative treatment. Other 
significant associated factors included etiology, liver cir-
rhosis, Child-Pugh stage, hemoglobin, AFP, and modified 
UICC stage.
Table 2 Causes of death within 30 days
TAE transcatheter arterial embolization




Hepatic failure Others P
Conservative treatment 35 32 21 9 2 0.211
TAE alone 21 7 2 4 1
Emergency surgery 79 6 4 2 0
Staged surgery 27 2 0 2 0
Summary 162 47 27 17 3
Fig. 1 Cumulative survival rates in four treatment groups
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Discussion
This study shows that the incidence of ruptured HCC is 
more in males, which corresponds with the skewed inci-
dence of HCC towards males observed worldwide. Infec-
tive causes of HCC predominate in our patients, which 
corresponds with the East Asian scenario. Child-Pugh 
class A predominated in our study, which is not the case 
in few of the recent publications where class B and C pre-
dominate (Jin et al. 2013). This could be because of early 
referrals in our hospitals.
Some studies have identified that hemorrhagic shock 
has a negative impact on short-term survival (Kiriko-
shi et  al. 2009; Hsueh et  al. 2012; Kim et  al. 2012). The 
degree of acute liver injury, hemoperitoneum and hemo-
dynamic instability had a major impact on 30  day mor-
tality Massive hemoperitoneum of ruptured HCC often 
leads to hemorrhagic shock, and fluid resuscitation may 
stabilize these patients. After emergency fluid resuscita-
tion, patients are classified as hemodynamically stable or 
not, and only some may be suitable for TAE or surgery. 
While some authors suggest that TAE and hepatectomy 
are important factors influencing short-term survival 
(Kirikoshi et al. 2009; Lin et al. 2014; Hsueh et al. 2012; 
Jin et  al. 2013), others regard TAE and staged hepatec-
tomy as prognostic factors (Tan et al. 2006; Hsueh et al. 
2012; Kung et al. 2008).
Most HCC tumors have a rich blood supply, and receive 
most blood from the hepatic artery. Therefore, since the 
pressure of arterial bleeding is higher, without surgery or 
TAE, the risk of continuous or repeated bleeding is high 
with conservative treatment, and impaired liver function 
can be exacerbated in patients not receiving interven-
tional hemostatic treatment. Chen et al. (2005) suggested 
that conservative treatment is preferable in patients with 
ruptured HCC, stating that emergency TAE does not offer 
significant advantages, as indicated by the disappoint-
ing prognosis. However, the present study findings dem-
onstrated that short-term and cumulative survival rates 
were significantly higher in patients who underwent TAE 
or hepatectomy than in those who received conserva-
tive treatment alone. Multivariate Cox-regression analy-
sis also showed that hepatectomy and TAE therapy were 
Fig. 2 Cumulative survival rates in patients who underwent conservative treatment and TAE/hepatectomy
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protective factors for survival as compared to conservative 
treatment. Hsueh et al. (2012) showed that ruptured HCC 
after TAE has better prognosis than after conservative 
treatment, and TAE may achieve successful hemostasis for 
ruptured HCC in 99 % of patients. TAE has replaced other 
surgical hemostatic methods, such as hepatic artery liga-
tion (Kung et al. 2008; Li et al. 2007; Castells et al. 2001). 
Although TAE can offer excellent hemostasis in ruptured 
HCC, we observed in this study that the therapeutic effect 
is apparently inferior to hepatectomy. Though the surgery 
may be difficult initially due to hemodynamic instabil-
ity, staged TAE followed by surgery in select patients can 
solve this problem as suggested by Li et  al. (2009). We 
opine that the role of TAE as the definitive or preliminary 
treatment might depend on the post-TAE recovery of liver 
function and re-evaluation of the patient’s clinical condi-
tion, and therefore, treatment should be tailored according 
to individual requirement. In the present study, post-TAE 
liver failure was observed in four (19.0 %) patients in the 
TAE group, which suggests that TAE should be selectively 
administered in patients with good reserved hepatic func-
tion and tolerable coagulopathy.
In this study, 65.4 % patients underwent partial hepa-
tectomy (emergency or staged), 29.6  % underwent TAE 
and only 21.6  % opted for conservative treatment. This 
could be because majority of patients were well preserved 
and fit for surgery in contrast to more numbers of unfit 
patients in other studies (Jin et al. 2013).
For all the patients in the present study, the 30-day 
and 1-year survival rates were 71.0 and 42.6 %, respec-
tively, which is reassuring. The 30-day and 1-year sur-
vival rates for patients receiving hepatectomy were 92.5 
and 59.4  %, respectively, which are higher than those 
reported in other studies (Liu et  al. 2001; Chen et  al. 
2005; Kirikoshi et al. 2009; Lai and Lau 2006; Yeh et al. 
2002; Tarantino et  al. 2011; Miyoshi et  al. 2010). This 
could be because of a selection bias due to early refer-
ral (72.9 % being Child-Pugh class A or B), better initial 
resuscitation and preserved liver function. With par-
tial hepatectomy, there is still a hope of cure for select 
patients even with spontaneously ruptured HCCs. 
Emergency hepatectomy combines the benefit of hemo-
stasis and a definitive treatment in a single surgical pro-
cedure. Some experts suggest that delayed hepatectomy 
Fig. 3 Cumulative survival rates in patients who underwent emergency hepatectomy, staged hepatectomy, or TAE
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after initial hemostasis might compromise the resection 
rate, because the rupture can aid in spread of the tumor. 
Findings from a single-center study concluded that one-
stage hepatectomy is a better option for patients with 
preserved liver function, whereas TAE is a better option 
for those with poorly preserved liver function (Yang 
et  al. 2014). Many report that TAE is a better modal-
ity for hemostasis in HCC rupture (Darnis et  al. 2014; 
Kirikoshi et  al. 2009; Lee et  al. 2014; Lin et  al. 2014; 
Hsueh et al. 2012; Kim et al. 2012; Jin et al. 2013; Yang 
et al. 2014), and in select patients, staged hepatectomy 
may be recommended thereafter (Lai and Lau 2006; Lee 
et al. 2014; Lin et al. 2014; Hsueh et al. 2012; Tarantino 
et  al. 2011). Thus, for patients arriving in the hospital 
with ruptured HCC with stable hemodynamics, accept-
able liver function, and tumor characteristics indicating 
Table 3 Cox-regression of independent variables to overall survival
AFP α-fetoprotein, ALT alanine aminotransferase, HBV hepatitis B virus, HCV hepatitis C virus, INR international normalized ratio, UICC Union for International Cancer 
Control, HR hazard ratio, CI confidence interval
* P < 0.05; ** P < 0.01; *** P < 0.001
Variables Estimated HR (95 % CI) P Adjusted HR (95 % CI) P
Treatment <0.001*** <0.001***
 Conservative treatment 1 – 1 –
TAE alone 0.04 (0.02–0.08) <0.001*** 0.05 (0.02–0.17) <0.001***
 Staged surgery 0.03 (0.01–0.06) <0.001*** 0.02 (0.00–0.09) <0.001***
 Emergency surgery 0.10 (0.05–0.20) <0.001*** 0.13 (0.03–0.50) 0.003**
Age (years) 1.04 (1.01–1.07) 0.019* 0.98 (0.93–1.04) 0.595
Gender (male) 1.24 (0.79–1.95) 0.353 0.37 (0.17–0.81) 0.012*
Etiology 0.028* <0.001*
 HBV 1 – 1 –
 HCV 1.30 (0.75–2.23) 0.349 0.97 (0.43–2.19) 0.936
 Others 0.36 (0.16–0.82) 0.015* 0.07 (0.02–0.27) <0.001***
Liver cirrhosis (yes) 7.25 (3.17–16.58) <0.001*** 4.73 (1.76–12.73) 0.002**
Child‑Pugh stage <0.001*** <0.001***
 A 1 – 1 –
 B 3.52 (2.28–5.44) <0.001*** 5.75 (2.86–11.54) <0.001***
 C 15.54 (9.64–25.05) <0.001*** 16.09 (5.43–47.65) <0.001***
Hemoglobin (g/L) 0.96 (0.94–0.98) <0.001*** 0.92 (0.87–0.98) 0.006**
Platelet (×109/L) 1.00 (0.99–1.00) 0.422 0.99 (0.97–1.00) 0.057
INR 4.13 (2.97–5.73) <0.001*** 1.51 (0.87–2.63) 0.144
Albumin (g/L) 0.88 (0.84–0.92) <0.001*** 1.03 (0.94–1.13) 0.528
Total bilirubin (mmol/L) 1.07 (1.06–1.09) <0.001*** 1.02 (0.99–1.05) 0.132
ALT (IU/L) 1.00 (1.00–1.01) <0.001*** 1.00 (1.00–1.00) 0.381
Creatinine (mg/dL) 0.48 (0.20–1.14) 0.097 0.15 (0.02–0.99) 0.049*
AFP (µg/L) 1.00 (1.00–1.00) 0.019* 1.00 (1.00–1.00) 0.012*
Size of lesions (cm) 0.98 (0.91–1.06) 0.662 0.80 (0.68–0.93) 0.004**
Multiple tumors (yes) 1.34 (0.95–1.89) 0.094 0.25 (0.09–0.73) 0.011*
Portal vein (yes) 1.13 (0.80–1.61) 0.486 8.63 (2.79–26.66) <0.001***
Modified UICC stage 0.002** 0.008**
 2 1 – 1 –
 3 1.13 (0.65–1.97) 0.657 5.20 (1.89–14.32) 0.001**
 4A 1.56 (0.92–2.64) 0.098 2.10 (0.75–5.86) 0.157
 4B 4.38 (1.92–10.02) <0.001*** 2.98 (0.65–13.55) 0.159
Morphology of lesions <0.001*** 0.247
 Nodular 1 – 1 –
 Infiltrative 3.29 (1.85–5.83) <0.001*** 1.19 (0.61–2.34) 0.604
 Pedunculated 2.14 (1.27–3.62) 0.004** 0.87 (0.48–1.58) 0.657
 Cirrhotomimetic 16.79 (7.02–40.18) <0.001*** 1.87 (0.65–5.38) 0.246
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resectability, emergency hepatectomy should be consid-
ered. For patients with equivocal clinical and laboratory 
parameters for hepatectomy or questionable expected 
post-hepatectomy liver function, TAE should be used 
as a temporary/bridging measure for hemostasis. The 
strategy of dealing with such difficult cases should be 
more aggressive to pursue longer survival times. In 
the present study, 106 patients underwent emergency 
hepatectomy or staged hepatectomy after TAE, and 
the 30-day and 1-year survival rates were better than in 
patients receiving conservative treatment. Patients with 
ruptured HCC without a prior diagnosis of liver cancer 
usually have reserve liver function, and can be stabilized 
with proper fluid resuscitation, thus, making them suit-
able candidates for surgery.
The limitations to this study are: firstly, the study was 
of retrospective design. Many patients were transferred 
from other regional hospitals, of whom, some may have 
undergone vigorous fluid resuscitation and been stabi-
lized, whereas others may not have been transferred at 
all; and secondly, there is a possibility of selection bias 
with only relatively healthy patients being transferred to 
these referral institutes. We do not consider this popula-
tion of patients to be representative of the general popu-
lation of HCC, but the treatment modalities need to be 
seriously considered in select patients. Thirdly, the treat-
ment choice in this study was based on patients’ general 
condition. Several demographic and clinical characteris-
tics, such as age, liver cirrhosis, Child-Pugh stage, hemo-
globin, platelet, INR, albumin, total bilirubin, creatinine, 
modified UICC stage, morphology of lesions, were signif-
icantly different among four groups. Therefore, a multi-
variable Cox model was used to adjust for these potential 
confounders. However, multivariable Cox-regression 
analysis also showed that liver cirrhosis, Child-Pugh 
stage and modified UICC stage were associated factors 
for overall survival. Hence, correlation between treat-
ment adopted and survival is biased by the selection of 
patients.
In conclusion, by the time patients with ruptured HCC 
were brought to the emergency department, they were 
already in hemorrhagic shock. TAE and partial hepatec-
tomy were found to be useful treatment strategies for 
hemorrhagic shock patients with spontaneous rupture 
of HCC. Partial hepatectomy, especially staged partial 
hepatectomy after TAE, tended to provide better survival 
than TAE alone. A multidisciplinary team comprising of 
surgeons, oncologists and radiologists should collaborate 
to implement a definitive treatment. Conservative treat-
ment may be best reserved for patients who are poor 
candidates for TAE or hepatectomy.
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